CUSIP: 773122106
This Amendment No. 1 (this “Amendment”) to Schedule 13D (the “Schedule 13D”) is being filed by Bessemer Venture Partners VIII Institutional L.P. (“BVP VIII Inst”), Bessemer Venture Partners VIII L.P. (“BVP VIII”, and together with BVP VIII Inst, the “BVP VIII Funds”), Deer VIII & Co. L.P. (“Deer VIII LP”), and Deer VIII & Co. Ltd., (“Deer VIII Co,” and collectively with the BVP VIII Funds and Deer VIII LP, the “Reporting Persons”), which is the general partner of Deer VIII LP. Capitalized terms used but not otherwise defined in this Amendment shall have the meanings ascribed to them in the Schedule 13D. Except as otherwise specifically amended in this Amendment, items in the Schedule 13D remain unchanged.
ITEM 5. | INTEREST IN SECURITIES OF THE ISSUER |
(a) As of March 3, 2022, BVP VIII Inst had sole voting and dispositive power with respect to 40,026,429 shares of Common Stock of the Issuer, constituting approximately 8.9% of the Issuer’s Common Stock.
As of March 3, 2022, BVP VIII had sole voting and dispositive power with respect to 33,282,043 shares of Common Stock of the Issuer, constituting approximately 7.4% of the Issuer’s Common Stock.
As of March 3, 2022, Deer VIII LP, as the general partner of each of the BVP VIII Funds may be deemed to have sole voting and dispositive power with respect to all 73,308,472 shares of Common Stock of the Issuer owned by the BVP VIII Funds, constituting approximately 16.3% of the Issuer’s Common Stock.
As of March 3, 2022, Deer VIII Co, as the general partner of Deer VIII LP may be deemed to have sole voting and dispositive power with respect to all 73,308,472 shares of Common Stock of the Issuer owned by the BVP VIII Funds, constituting approximately 16.3% of the Issuer’s Common Stock.
The percent of class was calculated based on 449,204,556 shares of Common Stock issued and outstanding as of November 9, 2021, as disclosed in the Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission by the Issuer on November 15, 2021.
The shares of Issuer’s Common Stock reported in this Item 5 do not include the Earnout Shares described in Item 4 of the Schedule 13D.
(b)
Regarding the number of shares as to which such person has:
(i) sole power to vote or to direct the vote: See line 7 of cover sheets
(ii) shared power to vote or to direct the vote: See line 8 of cover sheets
(iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets.
(iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets
(c) On March 3, 2022, BVP VIII Inst and BVP VIII distributed, for no consideration, 4,445,797 and 3,696,685 Shares, respectively, to their limited partners and to Deer VIII LP, representing each such partner’s pro rata interest in the Shares. On the same date, Deer VIII LP distributed, for no consideration, the Shares it received from the distributions to its partners in an amount equal to each such partner’s pro rata interest in the Shares.
(d) No other person is known to have the right to receive or the power to direct the receipt of dividends from, or any proceeds from the sale of, shares of the Issuer’s Common Stock beneficially owned by any of the Reporting Persons.
(e) Not applicable
ITEM 7. | MATERIAL TO BE FILED AS EXHIBITS |
Exhibit 99.1 Agreement regarding filing of joint Schedule 13D.